Taro Pharmaceutical (TARO) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sun Pharmaceutical Industries Limited has announced the completion of its merger with Taro Pharmaceutical Industries Ltd., making Taro a wholly-owned subsidiary and private entity. The merger is anticipated to enhance the combined entity’s competitive edge in the generic pharmaceuticals market. Sun Pharma, the majority shareholder of Taro since 2010, aims to leverage the merged strengths to foster growth and success.
For further insights into TARO stock, check out TipRanks’ Stock Analysis page.